BNET Industries
Last Fiscal Year Sales:$13.4B
- Private
- US
Dow Jones Description
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.
President, Product Development
Susan Desmond-Hellmann MDNumber of Employees 11,186
Contact Information
1 DNA Way
South San Francisco, California 94080-4990
(650) 225-1000
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Seattle Genetics and Genentech terminate collaboration agreement
-
When Google Runs Your Life
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Roche's Merger Formula for Genentech
-
Curis Reports Third Quarter 2009 Financial Results
-
Genentech's Levinson joins biotech startup's board
-
BUYINS.NET: FFIV, PTV, OSIP, RJF, CFR, DST Expected To Be Higher After Earnings Releases on...
-
Tuesday, Jul 28, 2009
-
Release Archives
-
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Research Collaboration with Genentech South SF DNA
-
Eden Biodesign Selected by Biotecnol SA for cGMP Production of Cardiotrophin-1 for Treatment of...
-
Former Genentech CEO Levinson Quits Google Board
-
PRESS DIGEST - Wall Street Journal - Oct 13
-
SurModics shares surge on $200M Roche pact
News & Analysis
Filter by
company and genentech inc. - All News and Analysis
ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO
WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) announced today the presentation of encouraging clinical findings with trastuzumab-DM1 (T-DM1) at the 2008 American Society of Clinical Oncology ASCO Annual Meeting taking place in Chicago, IL. T-DM1 comprises ImmunoGen's DM1 cell-killing agent linked to Genentech's HER2-targeting antibody, trastuzumab. Genentech is developing T-DM1...
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO
- Genentech Also Announces Decision to Advance Trastuzumab-DM1 to Phase II Testing -
Stock Alert for BTEM! May 23, 2007
Stock Market Alerts' performance stock list includes: BioStem, Inc. (OTCBB: BTEM), Genentech, Inc. (NYSE: DNA), Cerner Corp. (NASDAQ: CERN), Energy Conversion Devices, Inc. (NASDAQ: ENER). BioStem, Inc. (OTCBB: BTEM) is on the move and continues to issue good news, which should be of interest to investors. The company issued...
Speak with other shareholders about: (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG).
M2 PRESSWIRE-23 March 2007-Stockwire.com: Speak with other shareholders about: (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG)C1994-2007 M2 COMMUNICATIONS LTD RDATE:23032007 AUSTIN - A very interesting indicator to look for is where the money is flowing into. We have a filter...
Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG).
M2 PRESSWIRE-23 March 2007-RealPennies: Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG)C1994-2007 M2 COMMUNICATIONS LTD RDATE:23032007 RealPennies.com ALERTS: reporting on dollar volume movers: Healtheuniverse, Inc. (OTC: HLUN), Amgen Inc. (NASDAQ: AMGN), Genentech Inc. (NYSE: DNA),...
Healtheuniverse Researching Reconstructive Surgery Using Non-Embryonic Stem Cells.
M2 PRESSWIRE-23 March 2007-InvestSource Inc.: Healtheuniverse Researching Reconstructive Surgery Using Non-Embryonic Stem CellsC1994-2007 M2 COMMUNICATIONS LTD RDATE:23032007 Stocks in the News: Healtheuniverse, Inc. (OTC: HLUN), Amgen Inc. (NASDAQ: AMGN), Genentech Inc. (NYSE: DNA), Celgene Corp. (NASDAQ: CELG) For...
Stocks on the Rise.
M2 PRESSWIRE-7 June 2005-WallStreetGrapevine: Stocks on the RiseC1994-2005 M2 COMMUNICATIONS LTD RDATE:07062005 Wall Street, NYC-Today, wallstreetgrapevine.com, named; EDot.com, Inc. (Pink Sheets: ECMM), LaJolla Pharmaceutical Co. (Nasdaq NM: LJPC), Depomed Inc. (Nasdaq NM: DEPO), and Exelixis Inc. (Nasdaq NM: EXEL); their...
Zacks.com Announces That the Following Companies Will Release Earnings This Week: Alcoa, Apollo Group, Genentech, General Electric and Monsanto
CHICAGO -- Zacks.com releases it's exclusive Weekly Earnings and Sector Update written by Nick Raich, Director of Research. This vital update provides investors with timely information regarding companies that will be reporting their earnings in the coming week, how companies' earnings faired the week prior, exclusive sector rankings and earnings...
Technical Analysis: Pfizer, Yahoo, Veritas, Genentech
In light of important recent news events that are affecting the stock prices of the companies represented in this article, Stock Traders Daily has highlighted critical Technical Analysis for the companies herein so that Traders know how they should be reacting to the changes in stock prices for each company.
Curis Reports First Quarter 2004 Results
Business Editors CAMBRIDGE, Mass.--BUSINESS WIRE--April 28, 2004 Curis, Inc. (Nasdaq:CRIS), a therapeutic drug development company, today reported its financial results for the first quarter ended March 31, 2004. For the first quarter of 2004, the Company reported a net loss applicable to common stockholders of $4,038,000 or...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Susan Desmond-Hellmann MD | President, Product Development |
| David A. Ebersman | Executive Vice President and Chief Financial Officer |
| Hal Barron MD | Chief Medical Officer & Senior Vice President, Development |
| Stephen G. Juelsgaard | Executive Vice President, Secretary and Chief Compliance Officer |
| Ian T. Clark | Executive Vice President, Commercial |
| Patrick Y Yang PhD | Executive Vice President, Product Operations |
| Richard H Scheller PhD | Executive Vice President, Research |
| Marc Tessier-Lavigne | Senior Vice President, Res Drug Discovery |
| Robert Garnick | Senior Vice President, Regulatory, Quality & Compliance |
| Andrew C. Chan | Vice President, Immunology Res |
| Ann L. Lee | Vice President, Process Development |
| Anthony P. Hurley | Vice President, Fill, Finish Manufacturing |
| Ashraf Hanna | Vice President, Alliance Management & Pipeline Strategy Support |
| Charles Calderaro | Vice President, Corp Engineering |
| Charles Johnson | Vice President, Clinical Biotherapeutics |
| Claudia Estrin | Vice President, Decision Support & Commercial Innovation |
| Corsee D. Sanders | Vice President, Biometrics & Business Operations, Medical Affairs |
| David Broad | Vice President & General Manager, Oceanside Product Operations |
| David Schenkein | Vice President, Clinical Hematology & Oncology |
| Denise Smith-Hams | Vice President, HR |
| Francis Jackson | Vice President, Vacaville Prod Operations |
| Gary Harbour | Vice President, Commercial Quality, South San Francisco |
| Genesio Murano | Vice President, Regulatory Affairs |
| Gregory Baird | Vice President, Corp Communications |
| Gwendolyn Fyfe | Vice President, Clinical Hematology & Oncology |
| James P. Miller | Vice President |
| Jennifer E. Cook | Vice President, Marketing Development |
| John M Whiting | Vice President Finance, Treasury and Procurement |
| John Orwin | Vice President |
| John Pinion | Vice President, External Quality |
| Joseph Barta | Vice President, Compliance |
| Joseph S. McCracken | Vice President, Business Development |
| Karen McCormick | Vice President |
| Kenneth Hillan | Vice President, Development Sciences |
| Kent Lieginger | Vice President |
| Kevin McRaith | Vice President |
| Leonard Kanavy | Vice President, Commercial Operations |
| Markus Gemuend | Vice President, Manufacturing Collaborations |
| Martin Babler | Vice President |
| Michael D. Varney | Vice President, Small Molecule Drug Discovery |
| Michael P. Miller | Vice President, Sales & Marketing, HER Family |
| Pamela M. Klein | Vice President, Clinical Oncology |
| Peter Carberry | Vice President, Clinical Operations |
| Philippa Norman | Vice President, Global Supply Chain |
| Quinton C. Oswald | Vice President, Sales & Marketing |
| Richard B Brewer | Vice President, Marketing |
| Ronald C. Branning | Vice President, Quality, Global |
| Roy C. Hardiman | Vice President |
| Scott Carmer | Vice President, Sales & Marketing, Rituxan Immunology |
| Sean A. Johnston | Vice President |
| Timothy L. Moore | Vice President, Manufacturing, South San Francisco |
| Todd Pierce | Vice President, Corp IT |
| Todd Rich | Vice President, Clinical & Commercial Regulatory Affairs |
| Varun Nanda | Vice President |
| Vince Anicetti | Vice President, Prod Portfolio Management |
| Vishva Dixit | Vice President, Molecular Oncology Res |
| W. Robert Arathoon | Vice President, Corp Manufacturing Operations |
| Walter K. Moore | Vice President, Govt Affairs |
| William N. Anderson | Vice President, Sales & Marketing, Immunology |
| Herbert W. Boyer | Co Founder |
| Richard Axel | Co-founder |
| Avi Ashkenazi | Director |
| Dan Eaton | Director |
| Geoff Teeter | Director, Corp Communications |
| Hamilton Mixon | Director, Corp Security Services |
| Henry Lowman | Director, Engineering |
| Kathee Littrell | Director, Investor Relations |
| Lino Gonzalez | Senior Director |
| Lisa Tuomi | Associate Director, Investor Relations |
| Mark Sliwkowski | Director |
| Mary Stutts | Senior Director, Corp Communications |
| Mike Burchmore | Director, Prod Management |
| Nicholas Bruggen | Associate Director |
| Stuart Bunting | Director |
| Wai Wong | Director |
| Brad Failing | Area Manager, Sales, Managed Care |
| D. Searle | Manager, Marketing |
| Diane L. Parks | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care |
| Diane Schrick | Prod Manager, Development |
| Sam Burst | Division Manager, Sales |
| Robert Andreatta | Controller |
| Amos Smith | Consultant |
| Beni Wolf | |
| Bradley Wolk | Engr, Process Development |
| Chung Hsu | Engr, Process Development |
| Colin Watanabe | Programmer Analyst, Corp IT |
| Dorothy French | |
| Fred Cohen | |
| Janet Rossant | |
| Jonathan K.C. Knowles | Head, Global Research |
| Joseph L Goldstein | |
| Michael S Brown | |
| Napoleone Ferrara | |
| Nicholas van | |
| Paul Godowski | |
| Richard O Hynes | |
| Robert van Reis | Engr, Process Development |
| Wai Lee | |
| William Wood | |
| Charles A. Sanders | Director |
| Grant Heidrich | investor |
| Norman Fogelsong | Venture Investor |
| Susan Desmond | member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Debra L. Reed | Board of Directors |
| Erich Hunziker | Board of Directors |
| William M. Burns | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | President, Product Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President and Chief Financial Officer | Current |
| Aquaya | Executive Vice President and Chief Financial Officer | Current |
| Intarcia Therapeutics, Inc. | Director | Current |
| Oppenheimer & Co. Inc. | research analyst | Former |
| Brown University | Bachelor of Arts in Economics and International Relations | Former |
| Genentech, Inc. | member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Chief Medical Officer & Senior Vice President, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Secretary and Chief Compliance Officer | Current |
| Wilson Sonsini Goodrich & Rosati | associate | Former |
| Iowa State University | Master of Science degree | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech Foundation | Executive Vice President, Commercial Operations | Current |
| Genentech, Inc. | Executive Vice President, Commercial | Current |
| Vernalis plc | Board of Directors | Current |
| Genentech Foundation | General Manager | Former |
| Pharmacia Corporation | Former | |
| Southampton University | Bachelor of Science Degree In Biological Sciences | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Product Operations | Current |
| Merck & Co. Inc. | Former | |
| The Ohio State University | doctorate in electrical engineering and computer science | Former |
| University of Cincinnati | Master of Science in electrical engineering | Former |
| National Chiao Tung University | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Executive Vice President, Research | Current |
| Genentech Foundation | Executive Vice President, Research | Current |
| National Academy of Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Board of Directors | Current |
| The Academy of Arts & Sciences | Member | Current |
| National Academy of Sciences | Member | Current |
| Genentech Foundation | Senior Vice President, Research | Former |
| California Institute of Technology | doctorate | Former |
| University of Wisconsin | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Res Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President, Regulatory, Quality & Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Immunology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Fill, Finish Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Alliance Management & Pipeline Strategy Support | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Engineering | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Biotherapeutics | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Decision Support & Commercial Innovation | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Biometrics & Business Operations, Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President & General Manager, Oceanside Product Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Vacaville Prod Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Commercial Quality, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Hematology & Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Marketing Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President Finance, Treasury and Procurement | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, External Quality | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Development Sciences | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing Collaborations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Small Molecule Drug Discovery | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, HER Family | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Global Supply Chain | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Agensys, Inc. | President and CEO of Arca Discovery | Current |
| ARCA Discovery, Inc. | President and Chief Executive Officer | Current |
| Genentech, Inc. | Vice President, Marketing | Current |
| Crest Asset Management, Inc. | Partner | Current |
| Anesiva Inc. | Board of Directors | Current |
| Corus Pharma, Inc. | Board of Directors | Current |
| Agensys, Inc. | Board of Directors | Current |
| SRI International | Director | Current |
| ARCA Discovery, Inc. | Board of Directors | Current |
| Scios Inc. | Chief Executive Officer | Former |
| Scios, Inc. | CEO | Former |
| Scios Inc. | President | Former |
| Scios, Inc. | President | Former |
| Heartport, Inc. | Coo | Former |
| Johnson & Johnson | COO of Heartport | Former |
| Dendreon Corporation | Chairman | Former |
| American Heart Association, Inc. | chairman | Former |
| Dendreon Corporation | Board of Directors | Former |
| Northwestern University | M.B.A. | Former |
| Virginia Polytechnic Institute and State University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Quality, Global | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Rituxan Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Manufacturing, South San Francisco | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Clinical & Commercial Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Prod Portfolio Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Molecular Oncology Res | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Corp Manufacturing Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Govt Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Vice President, Sales & Marketing, Immunology | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co Founder | Current |
| University of California, San Francisco | Professor of Biochemistry | Current |
| Genentech, Inc. | Board of Directors | Current |
| Allergan, Inc. | Vice Chairman | Current |
| National Academy of Sciences | Board of Directors | Current |
| Allergan, Inc. | Board of Directors | Former |
| National Academy of Sciences | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Co-founder | Current |
| Columbia University | University Professor, Investigator | Former |
| University of California, San Francisco | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Corp Security Services | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Engineering | Current |
| The Johns Hopkins University | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Director, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director, Prod Management | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Associate Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Area Manager, Sales, Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Senior Vice President & General Manager, Specialty Therapeutics & Managed Care | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Prod Manager, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Division Manager, Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Columbia University | Visiting Professor | Current |
| Cambridge University | Visiting Professor | Current |
| Red Abbey, LLC | Senior Advisor | Current |
| Genentech, Inc. | Consultant | Current |
| Auckland University | Visiting Professor | Current |
| Incyte Corporation | Consultant | Current |
| University of Pennsylvania | Professor | Current |
| Merck & Co. Inc. | Consultant | Current |
| University of Pennsylvania | Chairman | Current |
| Kosan Biosciences, Inc. | Board Advisor | Current |
| Dihedron Corp | Board Advisor | Current |
| Pharmacopeia Drug Discovery Inc. | Board Advisor | Current |
| Provid Pharmaceuticals, Inc. | Board of Directors | Current |
| Monell Chemical Senses Center | Member | Current |
| The Rockefeller University | Research Associate | Former |
| The Rockefeller University | Ph.D. | Former |
| Bucknell University | M.S. Degrees | Former |
| Bucknell University | B.S. | Former |
| The Rockefeller University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Programmer Analyst, Corp IT | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current | |
| Washington State University | Scientist | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | Managing Director, Global Pharmaceutical Research | Current |
| Genentech, Inc. | Head, Global Research | Current |
| Genentech, Inc. | Board of Directors | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| University of East Anglia | Honours Degree in Molecular Genetics | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current | |
| University of California, San Francisco | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Engr, Process Development | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| The University of North Carolina | Trustee | Current |
| marketRx Inc. | Current | |
| Feinstein Kean Healthcare | Current | |
| Vertex Pharmaceuticals Incorporated | Chairman of the Board | Current |
| Venrock Associates | Chairman of the Board of Directors | Current |
| Foundation for the National Institutes of Health | Chairman, Executive Committee | Current |
| Icagen, Inc. | Chairman | Current |
| Project Hope | Chairman | Former |
| Drug Safety Alliance, Inc. | Board of Directors | Current |
| Icagen, Inc. | Board of Directors | Current |
| Kendle International Inc. | Director | Current |
| Cephalon, Inc. | Board of Directors | Current |
| Genentech, Inc. | Director | Current |
| Pharmacopeia Drug Discovery Inc. | Board of Directors | Current |
| Radius Ventures, LLC | Board of Directors | Current |
| Csis Inc | Board of Directors | Current |
| Cardioxyl Pharmaceuticals, Inc. | Board of Directors | Current |
| Trimeris, Inc. | Director | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Epiphany Biosciences, Inc. | Board of Directors | Current |
| Staffmark | Board of Directors | Current |
| Scios, Inc. | Director | Current |
| Reata Pharmaceuticals, Inc | Board of Directors | Current |
| Vrtx | Board of Directors | Current |
| Science & Technology Group | CEO | Former |
| Massachusetts General Hospital | General Director | Former |
| Harvard Medical School | director of Massachusetts General Hospital | Former |
| Massachusetts Gen Hospital | General Director | Former |
| Harvard Medical School | Professor of Medicine | Former |
| Meredith College | trustee | Former |
| Scios Inc. | Former | |
| New York Academy of Sciences | Chairman | Former |
| Vertex Pharmaceuticals Incorporated | Board of Directors | Current |
| Genaera Corporation | Board of Directors | Former |
| Reynolds Metals, Inc. | Board of Directors | Former |
| Squibb Corporation | Board Member | Former |
| Biopure Corporation | Director | Former |
| Massachusetts General Hospital | Director | Former |
| Squibb Corporation | Vice Chairman | Former |
| The University of Texas Southwestern Medical School | M.D. | Former |
| The University of Texas | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Roche Holding Ltd. | CFO | Current |
| F. Hoffmann-La Roche Ltd. | CFO | Current |
| Chugai Pharmaceutical Co., Ltd. | Board of Directors | Current |
| Genentech, Inc. | Board of Directors | Current |
| Holcim Ltd. | Board of Directors | Current |
| Diethelm Keller Holding Ltd. | Chief Executive Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Mayfield Fund | Partner Emeritus | Current |
| Prospect Venture Partners | Advisor | Current |
| Ngm Biopharmaceuticals, Inc. | Board of Directors | Current |
| DoveBid, Inc. | Director | Current |
| Cytokinetics, Inc. | Board of Directors | Current |
| Genentech, Inc. | investor | Current |
| Cytokinetics, Inc. | investor | Current |
| MIPS Technologies, Inc. | investor | Current |
| Immunex Corporation | investor | Current |
| DoveBid, Inc. | investor | Current |
| SGI Inc. | investor | Current |
| Amgen Inc. | investor | Current |
| Tularik, Inc. | investor | Current |
| Millennium Pharmaceuticals, Inc. | investor | Current |
| Western Association of Venture Capitalists | President | Former |
| Aveo Pharmaceuticals, Inc. | Former | |
| Mayfield | Former | |
| Tularik, Inc. | Chairman of the Board | Former |
| Millennium Pharmaceuticals, Inc. | Board of Directors | Former |
| Columbia University | MBA | Former |
| Stanford University | BA | Former |
| Organization | Position | Status |
|---|---|---|
| International Venture Partners, Inc. | General Partner | Current |
| Cortina Systems Corporation | Board of Directors | Current |
| Genentech, Inc. | Venture Investor | Current |
| Verisity, Ltd. | Venture Investor | Current |
| Aspect Software, Inc. | Investor | Current |
| 3Com Corporation | Venture Investor | Current |
| Cypress Semiconductor Corporation | Venture Investor | Current |
| Silicon Graphics, Inc. | Venture Investor | Current |
| Artisan Components, Inc. | Investor | Current |
| WebEx Communications, Inc. | Venture Investor | Current |
| MIPS Technologies, Inc. | Venture Investor | Current |
| LSI Corporation | Venture Investor | Current |
| Applied Biosystems Group | Venture Investor | Current |
| Dust Networks | Venture Investor | Current |
| Linear Technology Corp. | Venture Investor | Current |
| SupportSoft, Inc. | Venture Investor | Current |
| Concur Technologies, Inc. | Investor | Current |
| Compaq Computers | Investor | Current |
| Websense Inc. | Investor | Current |
| Lam Research Corporation | Investor | Current |
| Polycom, Inc. | Investor | Current |
| Motion Computing, Inc. | Investor | Current |
| @Road, Inc. | Venture Investor | Current |
| Amgen Inc. | Venture Investor | Current |
| Quantum Corporation | Venture Investor | Current |
| Digital River, Inc. | Venture Investor | Current |
| Institutional Venture Partners | General Partner | Former |
| Hewlett-Packard Company | computer programmer | Former |
| McKinsey & Company, Inc. | management consultant | Former |
| Stanford University | Board Member | Former |
| Harvard Law School | J.D | Former |
| Harvard Business School | M.B.A | Former |
| Stanford University | B.S. degree in Management Science & Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Genentech, Inc. | member | Current |
| The University of California, San Francisco | Assistant Professor | Former |
| University of California, Berkeley | Master of Science degree in Epidemiology and Biostatistics | Former |
| University of Nevada | Bachelor of Science in Pre-Medicine and her Medical Degree | Former |
| University of California, San Francisco | adjunct associate professor of Epidemiology and Biostatistics | Former |
Executive News
-
Genentech names Clark as CEO:
-
Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes; More...
-
Roche Names Pharma Chief
-
Genentech names new CEO
-
Genentech names new CEO
-
Roche Announces New Corporate Executive Committee
-
Roche moving Clark to CEO of Genentech
-
Severin Schwan finds his feet as Roche CEO
-
Facebook Reaps Recruits at High Levels
-
Facebook’s Zuck is on a personal mission — may expand staff 50 percent this year
-
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
